L&K Biomed Ltd. (KOSDAQ:156100)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,030.00
+60.00 (1.21%)
At close: Jun 10, 2026

L&K Biomed Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8,9763,1783,8355,0477,39516,108
Short-Term Investments
17,6083,10816,1087,7295,6083,108
Cash & Short-Term Investments
26,5846,28619,94312,77613,00319,216
Cash Growth
48.14%-68.48%56.10%-1.75%-32.33%133.88%
Accounts Receivable
19,84617,91214,9809,8395,7801,526
Other Receivables
1,144739.65290.261,066223.05635.92
Receivables
20,99018,93316,01510,9056,0032,162
Inventory
37,85734,65824,55119,08916,36613,856
Prepaid Expenses
618.24680.38525.95656.55444.63688.1
Other Current Assets
1,358612.062,532990.85330.622,042
Total Current Assets
87,40761,17063,56644,41736,14737,964
Property, Plant & Equipment
12,5779,61710,0059,0128,5149,271
Long-Term Investments
644.53644.53577.51,04964.151,203
Other Intangible Assets
1,1251,059998.17798.73715.111,209
Long-Term Accounts Receivable
3,4614,1401,8071,2812,3855,200
Long-Term Deferred Tax Assets
5,0835,2775,0095,5163,9023,591
Long-Term Deferred Charges
----106.09223.63
Other Long-Term Assets
1,4051,375798.55387.38829.96623.29
Total Assets
111,70283,48383,06162,76252,66359,285
Accounts Payable
2,7323,7813,3472,0472,437498.73
Accrued Expenses
1,441963.43851.44685.87589.86606.95
Short-Term Debt
23,93515,27920,55810,04020,4066,692
Current Portion of Long-Term Debt
1,1001,1008001002,800-
Current Portion of Leases
531.34706.84669.07828.69750.57636.63
Current Income Taxes Payable
207.17205.087.290.3554.090.89
Other Current Liabilities
23,50116,29612,8419,06210,9434,177
Total Current Liabilities
53,44838,33239,07422,76337,98112,613
Long-Term Debt
5005001,0001,700-13,608
Long-Term Leases
1,4311,562369.63845.161,2441,518
Pension & Post-Retirement Benefits
3,2493,1193,0572,2321,5741,330
Long-Term Deferred Tax Liabilities
1,1421,2161,5691,3611,047-
Other Long-Term Liabilities
124.77118.911,9583,27455.375,429
Total Liabilities
59,89444,84847,02832,17541,90234,499
Common Stock
11,17610,8939,9689,9686,7036,696
Additional Paid-In Capital
80,37773,69290,38690,38668,17467,992
Retained Earnings
-32,539-40,867-58,746-67,849-65,348-51,884
Treasury Stock
-0.09-0.09-0.09-0.09-0.09-0.09
Comprehensive Income & Other
271.021,759887.932,8462,7401,663
Total Common Equity
59,28445,47742,49635,35112,26824,467
Minority Interest
-7,477-6,842-6,463-4,764-1,507319.82
Shareholders' Equity
51,80838,63536,03330,58710,76224,787
Total Liabilities & Equity
111,70283,48383,06162,76252,66359,285
Total Debt
27,49719,14823,39713,51325,20122,456
Net Cash (Debt)
-912.93-12,861-3,454-737.76-12,198-3,240
Net Cash Per Share
-43.79-632.68-158.80-45.50-910.57-242.05
Filing Date Shares Outstanding
22.2721.7919.9419.9413.4113.39
Total Common Shares Outstanding
22.2721.7919.9419.9413.4113.39
Working Capital
33,95822,83824,49221,654-1,83425,351
Book Value Per Share
2662.472087.382131.561773.17915.171826.89
Tangible Book Value
58,16044,41841,49834,55311,55323,258
Tangible Book Value Per Share
2611.972038.782081.501733.11861.821736.61
Land
2,594737.02737.02737.02737.02737.02
Buildings
3,3732,5022,5022,5022,5022,502
Machinery
16,35316,00616,49114,30712,33011,671
Construction In Progress
-2559---